A scientist uses forceps to examine contents under microscope

A new era of neurological treatments

Novartis is proud to serve people living with neurological conditions around the globe. Above all, partnering with patients, healthcare professionals and healthcare systems to deliver life-changing solutions and treatments is at the core of what we do.

Multiple Sclerosis

Multiple sclerosis (MS) is a chronic disorder of the central nervous system. It disrupts the normal functioning of the brain, nervous system and spinal cord through inflammation of the myelin sheath which protects the nerve cells.

Learn More



Migraine is a complex and distinct neurological disease. It involves recurrent attacks of moderate-to-severe head pain and is associated with nausea, vomiting and sensitivity to light, sound and odors.

Learn More

Speak Your Migraine

Migraine is one of the top 10 causes of years lived with disability for men and women according to the World Health Organisation.

Speak your migraine is a platform with the key goal to empower patients by fostering a community and enable more productive conversations about migraine with their doctors and families.  If you or someone you love is suffering from migraine, encourage them to speak their migraine at our Facebook page (for those outside of the United States).

Learn More

Alzheimer’s Disease

It is estimated that around 44 million people globally have Alzheimer's or a related dementia. Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks of daily living. In most people with Alzheimer's, symptoms first appear after age 60. Although treatment can help manage symptoms in some people, currently there is no cure.

Novartis is currently conducting a clinical trial program targeting cognitively healthy individuals at risk to develop symptoms of Alzheimer’s disease. 

Learn More 

Specialty Neurology 

There are areas of high unmet need for people suffering from neuromuscular conditions such as sarcopenia and hip fracture recovery. Additionally, we are committed to the research of peripheral neuropathic pain, a chronic and debilitating condition.

Novartis Neuroscience News
"This is an exciting time in the treatment of chronic migraine, which has a profound impact on the lives of those who suffer from the disease."
Vas Narasimhan Chief Executive Officer, Novartis